Published on
July 3, 2020

Headlines | July 3, 2020

Companies Mentioned
No items found.
People Mentioned


Market performance of featured public psychedelic companies for the week of June 29th - July 3rd.


Mydecine Innovations Group ($MYCO | $MYCOF | $0NF) added world renowned drug discovery expert Dr. Denton Hoyer to its Scientific Advisory Board. Press Release
Cybin Corp (Private) announced a reverse take-over transaction and concurrent private placement of up to C$21M. Cybin has raised approximately C$10.4M to date. Press Release
Field Trip Psychedelics (Private) launched Basecamp, a program focused on serving combat veterans, first responders, emergency room doctors and other frontline professionals regularly exposed to traumatic experiences while on the job. Press Release
Entheon Biomedical (Private) announced amalgamation plans with MPV Exploration and a concurrent financing. Press Release
View All News


Prominent global biotech investors Greg Bailey and Jim Mellon have invested in Beckley Psytech, a new company developing a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases. Press Release
The Oregon Psilocybin Therapy Initiative announced that it had received the necessary amount of signatures to put IP 34 on November's ballot. The measure would legalize the use of psychedelic mushrooms in controlled doses when administered by professionals in the state. Oregon would become the first state to legalize the substance if the ballot measure is successful. The Hill
TheraPsil, a non-profit coalition that has been helping terminally ill Canadians apply for drug exemptions to pursue psilocybin therapy, is now helping doctors apply for their own exemptions so they “may personally try psilocybin and properly train in psychedelic-assisted psychotherapy." Link
Psychedelic Finance interviewed Dr. David E. Nichols, Founding President of the Heffter Research Group. Link


View Spotlight Interviews

View Companies